AMD and Retinal Disease News

  • Alert FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy The VEGF inhibitor is already approved for neovascular (wet) age-related macular degeneration, macular edema after central retinal vein occlusion, and diabetic macular edema.
  • Drusen Characteristics Linked With AMD Risk in Fellow Eyes In patients with unilateral neovascular age-related macular degeneration (AMD), certain drusen features are associated with conversion to neovascular AMD in the fellow eye, according to a secondary analysis of data from a clinical trial.

AMD and Retinal Disease Perspective


AMD and Retinal Disease Journal Articles